A John Camm Selected Research

Amiodarone (Amiodarona)

1/2020	Evaluation of the Switch From Amiodarone to Dronedarone in Patients With Atrial Fibrillation: Results of the ARTEMIS AF Studies.
2/2014	Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines.
5/2012	Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey.
1/2011	A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.
7/2008	Safety considerations in the pharmacological management of atrial fibrillation.
2/2006	Turbulence dynamics: an independent predictor of late mortality after acute myocardial infarction.
12/2004	Turbulence slope after atrial premature complexes is an independent predictor of mortality in survivors of acute myocardial infarction.
9/2004	Prevalent low-frequency oscillation of heart rate: novel predictor of mortality after myocardial infarction.
9/2003	Effect of amiodarone on the descending limb of the T wave.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A John Camm Research Topics

Disease

168	Atrial Fibrillation 03/2024 - 08/2002
85	Stroke (Strokes) 05/2024 - 11/2005
42	Hemorrhage 01/2024 - 01/2008
30	Heart Failure 05/2024 - 11/2002
26	Cardiac Arrhythmias (Arrythmia) 01/2023 - 04/2002
20	Embolism (Embolus) 01/2024 - 09/2002
16	Myocardial Infarction 05/2024 - 09/2002
15	Ventricular Tachycardia 03/2024 - 01/2003
14	Coronary Artery Disease (Coronary Atherosclerosis) 05/2024 - 10/2004
11	Acute Coronary Syndrome 05/2024 - 09/2002
10	Bradycardia 11/2023 - 12/2003
9	Ischemic Stroke 01/2024 - 05/2013
9	Heart Diseases (Heart Disease) 01/2022 - 01/2002
9	Torsades de Pointes (Torsade de Pointes) 01/2016 - 12/2003
6	Cardiac Sudden Death (Sudden Cardiac Arrest) 10/2022 - 01/2002
6	Tachycardia (Tachyarrhythmias) 01/2019 - 09/2002
6	Neoplasms (Cancer) 01/2018 - 05/2013
5	Thromboembolism 01/2023 - 09/2002
5	Left Ventricular Dysfunction 01/2022 - 11/2002
5	Atrial Flutter (Flutter, Atrial) 01/2022 - 09/2002
5	Hypertension (High Blood Pressure) 05/2021 - 05/2012
5	Inflammation (Inflammations) 01/2020 - 09/2002
5	Chronic Renal Insufficiency 01/2019 - 05/2013
4	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 09/2002
4	Diabetes Mellitus 10/2023 - 12/2019
4	Liver Diseases (Liver Disease) 01/2023 - 01/2002
4	Brugada Syndrome 01/2010 - 05/2009
3	Cardiomyopathies (Cardiomyopathy) 01/2023 - 02/2003
3	Vascular Diseases (Vascular Disease) 05/2021 - 12/2019
3	Fibrosis (Cirrhosis) 04/2016 - 03/2011
3	Sudden Death 08/2010 - 01/2002
2	Cough 03/2024 - 01/2022
2	Pain (Aches) 03/2024 - 01/2022
2	Supraventricular Tachycardia 01/2023 - 06/2004
2	Cognitive Dysfunction 01/2022 - 12/2009
2	Peripheral Arterial Disease 06/2021 - 11/2018
2	Venous Thrombosis (Deep-Vein Thrombosis) 11/2018 - 08/2011
2	Confusion (Bewilderment) 01/2018 - 01/2018
2	Atrioventricular Block 01/2017 - 03/2008
2	Ventricular Fibrillation 01/2016 - 06/2006
2	Heart Valve Diseases (Valvular Heart Disease) 05/2012 - 02/2003
2	Long QT Syndrome 08/2009 - 01/2002
2	Shock 01/2008 - 12/2003

Drug/Important Bio-Agent (IBA)

62	AnticoagulantsIBA 03/2024 - 09/2002
40	Vitamin K FDA Link 03/2024 - 01/2012
24	Anti-Arrhythmia AgentsIBA 11/2023 - 11/2002
22	RivaroxabanIBA 06/2021 - 01/2014
12	N(4)-oleylcytosine arabinosideIBA 06/2021 - 05/2013
11	Dronedarone FDA Link 06/2023 - 10/2008
10	Warfarin (Coumadin)FDA LinkGeneric 12/2022 - 01/2008
9	edoxabanIBA 11/2023 - 08/2011
9	Amiodarone (Amiodarona)FDA LinkGeneric 01/2020 - 09/2003
7	etripamilIBA 03/2024 - 11/2022
6	Factor Xa InhibitorsIBA 02/2022 - 08/2011
6	vernakalantIBA 02/2014 - 03/2008
5	Flecainide (Tambocor)FDA LinkGeneric 05/2024 - 03/2007
5	apixabanIBA 11/2023 - 01/2014
5	Dabigatran FDA Link 11/2016 - 01/2012
5	Ion Channels (Ion Channel)IBA 04/2016 - 08/2009
4	Nasal SpraysIBA 03/2024 - 01/2023
4	Sotalol (Sotalol Hydrochloride)FDA LinkGeneric 06/2023 - 06/2017
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2011 - 10/2008
3	Propafenone (Rythmol)FDA LinkGeneric 05/2024 - 03/2007
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2023 - 07/2017
3	Bisoprolol (Concor)FDA LinkGeneric 12/2020 - 11/2003
3	C-Reactive ProteinIBA 01/2020 - 09/2002
3	Ranolazine FDA Link 10/2015 - 05/2015
3	IvabradineIBA 07/2015 - 01/2006
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2011 - 07/2005
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2011 - 06/2006
3	Ajmaline (Wolfina)FDA Link 01/2010 - 05/2009
3	azimilideIBA 08/2006 - 03/2004
2	SolutionsIBA 03/2024 - 01/2022
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2023 - 07/2015
2	Moxifloxacin (Avelox)FDA Link 10/2022 - 09/2014
2	dofetilide (Tikosyn)FDA Link 01/2022 - 07/2008
2	AntithrombinsIBA 05/2021 - 05/2014
2	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 07/2014
2	Digoxin (Digitek)FDA LinkGeneric 12/2020 - 12/2014
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2008
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 10/2018 - 01/2017
2	amiselimodIBA 10/2018 - 01/2017
2	CalciumIBA 04/2016 - 03/2011
2	vanoxerine (I 893)IBA 01/2016 - 06/2015
2	Fish OilsIBA 09/2011 - 06/2006
2	Angiotensin Receptor AntagonistsIBA 05/2011 - 10/2008
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2008 - 06/2006
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2008 - 03/2005

Therapy/Procedure

81	Therapeutics 05/2024 - 01/2002
33	Electric Countershock (Cardioversion) 03/2024 - 09/2002
15	Catheter Ablation 12/2023 - 04/2002
10	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2024 - 01/2002
9	Defibrillators (Defibrillator) 11/2023 - 04/2003
8	Catheters 01/2023 - 08/2002
4	Secondary Prevention 01/2022 - 01/2008
3	Drug Therapy (Chemotherapy) 01/2024 - 05/2013
3	Radiofrequency Ablation 01/2021 - 06/2008
2	Duration of Therapy 05/2024 - 07/2014
2	Percutaneous Coronary Intervention 11/2018 - 04/2018